Reduction in Hepatitis C-Related Liver Disease Associated With GB Virus C in Human Immunodeficiency Virus Coinfection

Gastroenterology

Volumn 133, Issue 6, 2007, Pages 1821-1830

  Berzsenyi, Mark D ^a   Bowden, D Scott ^b   Kelly, Heath A ^b   Watson, Kerrie M ^a   Mijch, Anne M ^a   Hammond, Rachel A ^b   Crowe, Suzanne M ^c   Roberts, Stuart K ^a  

^a ALFRED HOSPITAL   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 36549030411     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.08.076     Document Type: Article

References (36)

1. Linnen J., Wages Jr. J., Zhang-Keck Z.Y., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271 (1996) 505-508
2. Leary T.P., Muerhoff A.S., Simons J.N., et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 48 (1996) 60-67
3. Berzsenyi M.D., Bowden D.S., and Roberts S.K. GB virus C: insights into co-infection. J Clin Virol 33 (2005) 257-266
4. Tucker T.J., Smuts H.E., Eedes C., et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 61 (2000) 52-58
5. Xiang J., Wunschmann S., Schmidt W., et al. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 74 (2000) 9125-9133
6. Bjorkman P., Naucler A., Winqvist N., et al. A case-control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection. Vox Sang 81 (2001) 148-153
7. Lefrere J.J., Roudot-Thoraval F., Morand-Joubert L., et al. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion 39 (1999) 83-94
8. Scallan M.F., Clutterbuck D., Jarvis L.M., et al. Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 55 (1998) 203-208
9. Sawayama Y., Hayashi J., Etoh Y., et al. Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan. Dig Dis Sci 44 (1999) 1937-1943
10. Polgreen P.M., Xiang J., Chang Q., et al. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect 5 (2003) 1255-1261
11. Heringlake S., Ockenga J., Tillmann H.L., et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?. J Infect Dis 177 (1998) 1723-1726
12. Lefrere J.J., Roudot-Thoraval F., Morand-Joubert L., et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 179 (1999) 783-789
13. Yeo A.E., Matsumoto A., Hisada M., et al. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 132 (2000) 959-963
14. Tillmann H.L., Heiken H., Knapik-Botor A., et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345 (2001) 715-724
15. Xiang J., Wunschmann S., Diekema D.J., et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345 (2001) 707-714
16. Williams C.F., Klinzman D., Yamashita T.E., et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350 (2004) 981-990
17. Bjorkman P., Flamholc L., Naucler A., et al. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. Aids 18 (2004) 877-886
18. Van der Bij A.K., Kloosterboer N., Prins M., et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 191 (2005) 678-685
19. Birk M., Lindback S., and Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. Aids 16 (2002) 2482-2485
20. Brumme Z.L., Chan K.J., Dong W.W., et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. Aids 16 (2002) 1929-1933
21. Rambusch E.G., Wedemeyer H., Tillmann H.L., et al. Significance of coinfection with hepatitis G virus for chronic hepatitis C-a review of the literature. Z Gastroenterol 36 (1998) 41-53
22. Bowden S. New hepatitis viruses: contenders and pretenders. J Gastroenterol Hepatol 16 (2001) 124-131
23. Benhamou Y., Bochet M., Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30 (1999) 1054-1058
24. Qurishi N., Kreuzberg C., Luchters G., et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 362 (2003) 1708-1713
25. Oshita M., Hayashi N., Mita E., et al. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy. J Med Virol 55 (1998) 98-102
26. Yu M.L., Chuang W.L., Dai C.Y., et al. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-α therapy. Antiviral Res 52 (2001) 241-249
27. Tacke M., Schmolke S., Schlueter V., et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26 (1997) 1626-1633
28. Bellentani S., Tiribelli C., Saccoccio G., et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 20 (1994) 1442-1449
29. Moaven L.D., Locarnini S.A., Bowden D.S., et al. Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. J Hepatol 27 (1997) 613-619
30. Smith D.B., Basaras M., Frost S., et al. Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol 81 (2000) 769-780
31. Schwarze-Zander C., Blackard J.T., Zheng H., et al. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 194 (2006) 410-419
32. Masuko K., Mitsui T., Iwano K., et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 334 (1996) 1485-1490
33. Dille B.J., Surowy T.K., Gutierrez R.A., et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 175 (1997) 458-461
34. Mohsen A.H., Easterbrook P., Taylor C.B., et al. Hepatitis C and HIV-1 coinfection. Gut 51 (2002) 601-608
35. Xiang J., McLinden J.H., Chang Q., et al. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A 103 (2006) 15570-15575
36. Shields P.L., Morland C.M., Salmon M., et al. Chemokine and chemokine receptor interactions provide a mechanism for selective T-cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163 (1999) 6236-6243